Sure, here is the content you requested:
Until about 10 years ago, psychoactive substances not listed for control within the conventions tended to emerge on the illicit drug market. They were limited to a handful of substances each year, which were typically passed off as controlled drugs such as MDMA.The market for new psychoactive substances is characterised by the large number of substances that have emerged, with new ones being detected each year. on this page, you can find an overview of the drug situation for new psychoactive substances in Europe, supported by information from the EU early Warning System on seizures and substances.
This drug has been present in Europe sence last year. So far, drastic cases have not yet been found, but there are in different countries. That is why we try to inform about all different types of hazardous drugs, synthetic and semi-synthetic substances, Bakalov explained.
Nowadays, false dosage forms of oxycodone or similar are sold in which fentanyl or so-called “elephant anesthesia” to enhance the effect. The latest trends in Europe are the use of a new type of opioid from the group of nitaes, which are between 500 and 1000 times more powerful than fentanyl.
The problem is that most drugs are already produced in the territory of all EU countries,Bakalov said. The problem of psychoactive substances nowadays exceeds the efforts of one or two institutions.
Electronic cigarettes are currently at least harmless in terms of the ability to add psychoactive substances, the expert added.
Emerging Threats: The Rise of New Psychoactive Substances in europe
Table of Contents
In recent years, the illicit drug market has seen a surge in the emergence of new psychoactive substances (NPS) not previously controlled by international conventions. These substances have posed significant challenges to law enforcement and public health across Europe. In this interview, the Senior Editor of world-today-news.com sat down with Dr. Ivan Bakalov, an expert on the subject, to discuss the current state and trends of NPS in Europe.
Overview of New Psychoactive Substances
Senior Editor: Can you provide an overview of the current situation with new psychoactive substances in Europe?
Dr. Ivan Bakalov: certainly. Over the past decade, we’ve seen a dramatic increase in the number of new psychoactive substances emerging on the illicit market. unlike in the past,when only a few substances woudl appear each year,we now detect new ones annually. This is largely due to advancements in synthetic chemistry and the ease of information sharing online, which allows manufacturers to quickly adapt and produce new compounds.
The EU Early Warning System
Senior Editor: How does the EU Early Warning System contribute to managing this issue?
Dr. Ivan Bakalov: The EU Early Warning System plays a crucial role in monitoring and responding to the emergence of new psychoactive substances. It provides real-time information on seizures and the detection of new substances across Europe. This data helps inform policy decisions and enables law enforcement agencies to stay ahead of the curve in identifying and addressing new threats.
Emerging Trends in NPS
Senior Editor: What are some of the latest trends in the use of NPS in europe?
Dr. Ivan Bakalov: One of the most concerning trends is the use of highly potent opioids, such as nitazenes, which are between 500 and 1000 times more powerful than fentanyl. These substances are often sold as false dosage forms of oxycodone or similar drugs,but they contain fentanyl or other potent opioids to enhance the effect. this poses a significant risk to public health, as these substances can be extremely dangerous and even deadly in small doses.
The production and Distribution of NPS
senior editor: Where are these substances being produced, and how are they being distributed?
Dr. Ivan Bakalov: Most NPS are now being produced within the EU itself. This complicates the issue considerably, as it means that the problem is not limited to cross-border trafficking. The distribution frequently enough involves online sales and the use of encrypted messaging platforms,which makes it challenging for law enforcement to track and disrupt these activities.
The Role of Institutions
Senior Editor: How do you think the efforts of various institutions can be improved to address this issue?
Dr. Ivan Bakalov: The problem of psychoactive substances has grown beyond the capacity of a single institution. It requires a coordinated effort involving law enforcement, public health agencies, and policy makers. Collaboration and information sharing among these stakeholders are essential to effectively combat the spread of NPS.
Electronic cigarettes and NPS
Senior Editor: What is the current status of electronic cigarettes in relation to NPS?
Dr. Ivan bakalov: As of now, electronic cigarettes are not being used to deliver psychoactive substances.Though, the technology exists, and it’s something that we need to keep an eye on. The potential for misuse is there, and it’s vital to stay vigilant to prevent any future misuse of e-cigarettes for delivering NPS.
Conclusion
Senior Editor: What are the main takeaways from our discussion today?
Dr. Ivan Bakalov: The main takeaways are the rapid emergence of new psychoactive substances, the need for coordinated efforts among institutions, and the potential risks posed by highly potent opioids. Awareness and vigilance are key to addressing this complex and evolving issue.
